<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d221">
    <sentence id="DDI-DrugBank.d221.s0" text="The risk of a potential interaction between NovoSeven and coagulation factor concentrates has not been adequately evaluated in preclinical or clinical studies.">
        <entity charOffset="44-52" id="DDI-DrugBank.d221.s0.e0" text="NovoSeven" type="brand"/>
        <entity charOffset="58-75" id="DDI-DrugBank.d221.s0.e1" text="coagulation factor" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d221.s0.e0" e2="DDI-DrugBank.d221.s0.e1" id="DDI-DrugBank.d221.s0.p0"/>
    <negationtags>The risk of a potential interaction between NovoSeven and coagulation factor concentrates has &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been adequately evaluated in preclinical or clinical studies. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d221.s1" text="Simultaneous use of activated prothrombin complex concentrates or prothrombin complex concentrates should be avoided.">
        <entity charOffset="20-61" id="DDI-DrugBank.d221.s1.e0" text="activated prothrombin complex concentrates" type="group"/>
        <entity charOffset="66-97" id="DDI-DrugBank.d221.s1.e1" text="prothrombin complex concentrates" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d221.s1.e0" e2="DDI-DrugBank.d221.s1.e1" id="DDI-DrugBank.d221.s1.p0"/>
    </sentence>
    <sentence id="DDI-DrugBank.d221.s2" text="Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., tranexamic acid, aminocaproic acid) and NovoSeven.">
        <entity charOffset="170-184" id="DDI-DrugBank.d221.s2.e0" text="tranexamic acid" type="drug"/>
        <entity charOffset="187-203" id="DDI-DrugBank.d221.s2.e1" text="aminocaproic acid" type="drug"/>
        <entity charOffset="210-218" id="DDI-DrugBank.d221.s2.e2" text="NovoSeven" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d221.s2.e0" e2="DDI-DrugBank.d221.s2.e1" id="DDI-DrugBank.d221.s2.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d221.s2.e0" e2="DDI-DrugBank.d221.s2.e2" id="DDI-DrugBank.d221.s2.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d221.s2.e1" e2="DDI-DrugBank.d221.s2.e2" id="DDI-DrugBank.d221.s2.p2"/>
    <negationtags>Although the specific drug interaction was &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., tranexamic acid, aminocaproic acid) and NovoSeven. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d221.s3" text="NovoSeven should not be mixed with infusion solutions until clinical data are available to direct this use.">
        <entity charOffset="0-8" id="DDI-DrugBank.d221.s3.e0" text="NovoSeven" type="brand"/>
    <negationtags>NovoSeven should &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be mixed with infusion solutions until clinical data are available to direct this use. &lt;/scope&gt;</negationtags></sentence>
</document>